含硼替佐米方案诱导序贯自体造血干细胞移植治疗多发性骨髓瘤——单中心200例长期随访结果

OBJECTIVE: To study the efficacy, safety and long-term outcomes of integrated strategy of bortezomib-based induction regimens followed by autologous hematopoietic stem cell (ASCT) and maintenance therapy in Chinese multiple myeloma (MM) patients. METHODS: 200 MM patients receiving integrated strateg...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2019
Materias:
论著
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342406/
https://www.ncbi.nlm.nih.gov/pubmed/31340616
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.06.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342406/
https://www.ncbi.nlm.nih.gov/pubmed/31340616
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.06.002

Ejemplares similares